* FY'25e adj. EBIT NOK 81m * Accretive acquisition * Fair value range of NOK 15-25 '25e adj.
* Q4 EBITDA of NOK 5m * Awaiting improved markets * '26e-'27e estimates down – fair value range of N...
Koppar, silver och guld återfinns i Bluelakes huvudprojekt Joma och Stekenjokk-Levi.
Ahead of Atria's Q4 report, we maintain our estimates intact.
EQL Pharma rapporterade ett starkt Q3 2025/26 med rekordomsättning och en tydlig lönsamhetsförbättri...
Hyresintäkterna steg 49% till 61,7 MEUR tack vare stora polska förvärv, högre uthyrning och indexeri...
Redeye briefly comments on the Q4 royalties for Leqembi, which came in roughly as expected.
Redeye provides a short comment on the Q4 report. We also highligt that following the acquisitions o...
Consti’s outlook for 2026 was on the softer side, with the challenging market conditions not showing...
YIT as expected saw a return to growth in Q4 and healthy profitability figures.
Investors House reported Q4 revenues of EUR 1.8m, 9% above our estimate.
Redeye updates its estimates and valuation after Lagercrantz’s Q3 2025/2026 report.
Redeye lowers its forecast following I-Tech’s soft Q4’25 figures.
Berner Industrier delivered another strong year in 2025, with margin gains and cost discipline lifti...
Redeye revises its base case to SEK10(SEK12) following AVTECH's Q4 2025 results, which fell 11% shor...
Redeye comments on Gapwaves' Q4 2025 report, which exceeded expectations on both net sales and adjus...
Redeye strengthens its positive view of Vitec following the Q4 report.
* 2026 recovery after two challenging years * '26e-'27e EBIT down 35-24%; ~60% EBIT CAGR '25-'28e * ...
Fractal’s share price has fallen sharply as the market prices in prolonged weakness in PC demand and...
Tagmaster finished 2025 with record level sales and earnings in the fourth quarter.
